Celltrion holdings Nasdaq

South Korean biopharmaceutical company Celltrion Healthcare Co. revealed on Monday its introduction of Remsima SC, a treatment for autoimmune diseas...

Hyundai Motor Co., in celebration of the first anniversary of its reentry into the Japanese market, is introducing a locally tailored "assurance pro...

The world’s two leading smartphone makers Apple Inc. and Samsung Electronics Co. employ different management strategies for their surplus mone...

HL Holdings Corp., a major South Korean automotive parts logistics specialist with a three-decade history, has joined hands with Veluga Brewery Inc....

Jang Se-joo, former chairman of South Korea’s Dongkuk Steel Mill Co., has returned to the top post after an eight-year hiatus as the steelmake...

Hanwha Q Cells Co., a unit of South Korea’s chemicals-to-construction conglomerate Hanwha Group, secured the top position in the US resid...

South Korea’s online giant Naver Corp. reported better-than-expected quarterly earnings thanks to strong sales of Poshmark Inc. in the US. It ...

Celltrion Inc. announced on Tuesday it has decided not to pursue the acquisition of the biopharmaceutical unit of U.S. medical device maker Baxter I...

South Korean Minister of Trade, Industry and Energy Lee Chang-yang discussed ways to strengthen industrial and trade cooperation with Lászl&o...

EcoPro BM Co., the top stock on South Korea’s junior bourse Kosdaq, declined on Wednesday as some brokerage houses have downgraded the shares ...

POSCO Holdings Inc., the holding company of the world’s sixth-largest steel maker, will directly produce nickel, a key material for sec...

South Korea’s Celltrion Inc. is speeding up global clinical trials of its biosimilar of the multiple sclerosis (MS) treatment Ocrevus (active ...

South Korean biopharmaceutical company Celltrion Healthcare Co. on Thursday said it ranked in the top 10 out of 400 companies last year on the Turki...

In Russia, which is in a state of war against Ukraine, there’s another war going on. This time, the war is between South Korea’s two lar...

POSCO Holdings said on Thursday that it has opened a headquarters for POSCO N.EX.T Hub, which will lead the R&D efforts for the entire POSCO G...

Shinhan Financial Group's Chairman Jin Ok-dong is set to embark on his first overseas business trip since taking office as chairman last month. From...

Michael ByungJu Kim, co-founder and partner at private equity firm MBK Partners, has topped the ranking of the 50 richest South Koreans by net worth...

Pohang University of Science and Technology (POSTECH), set up by South Korea’s steel giant POSCO Group in 1986 as a research university in the...

South Korea's Celltrion Healthcare Co. on Monday said it launched on the US market Vegzelma, a biosimilar of Bevacizumab, a medication for colorecta...

Concerns are growing about the financial health of South Korean luxury fashion e-commerce platform operator Balaan Co. after its net loss doubled on...

South Korea's Shinsegae Department Store has launched activities to support the overseas expansion of up-and-coming domestic fashion brands. The com...

Business representatives from South Korea and Japan gathered for the first time in six years, with the Korea Chamber of Commerce and Industry (KCC...

South Korea’s central bank was widely expected to leave its policy interest rate unchanged this week as inflation slows amid fears of a recess...

The super-rich in South Korea are eyeing stocks for investments despite a slowdown in Asia’s fourth-largest economy this year, expecting the l...

Kyobo Life Insurance Co. has completed the process to put a South Korea-based alternative asset investment company under its wing, a move that is ex...

A sibling feud over management control of DB Group is expected to intensify following the ascent of South Korean activist fund Korea Corporate Gover...

South Korea’s JB Financial Group Co. won a proxy battle against local activist fund Align Partners Capital Management on dividends and nominat...

South Korean leading foundry chipmaker DB HiTek’s stock price hit a near 10-month high this week as a domestic activist fund bought a stake to...

South Korean biosimilar giant Celltrion Group aims to transform into a drug developer by generating 40% of sales from new medicines by 2030 as it is...

South Korean biosimilar giant Celltrion Group’s founder Seo Jung-jin has returned to management two years after his departure, pledging to mer...